National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

dextroamphetamine-amphetamine
A combination of two synthetic agents with central nervous system stimulant activity. Both agents are non-catecholamine, sympathomimetic agents that elevate blood pressure and cause bronchodilation. These agents are commonly abused psychostimulant drugs that induce psychologic dependence manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. Tolerance to various effects develops unequally, so that tachycardia and enhanced alertness diminish while psychotoxic effects (hallucinations and delusions) may occur. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:D,L-amphetamine
US brand names:Adderall
Adderall XR
Abbreviation:SLI381



Previous:Dex-4, Dexace, Dexameth, dexamethasone, dexrazoxane hydrochloride
Next:dexverapamil, Dezone, DHA-paclitaxel, DHEA mustard, DI-Leu16-IL2 immunocytokine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov